Incyte Market Capitalization from 2010 to 2024
| INCY Stock | USD 75.45 0.65 0.87% |
Check Incyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Incyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 86.8 M, Interest Expense of 2.4 M or Total Revenue of 3.9 B, as well as many indicators such as Price To Sales Ratio of 3.61, Dividend Yield of 0.0 or PTB Ratio of 2.84. Incyte financial statements analysis is a perfect complement when working with Incyte Valuation or Volatility modules.
Incyte | Market Capitalization |
Latest Incyte's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Incyte over the last few years. It is Incyte's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Incyte's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 14.41 B | 10 Years Trend |
|
Market Cap |
| Timeline |
Incyte Market Capitalization Regression Statistics
| Arithmetic Mean | 13,884,836,396 | |
| Geometric Mean | 10,561,673,257 | |
| Coefficient Of Variation | 30.17 | |
| Mean Deviation | 2,725,063,825 | |
| Median | 16,179,415,200 | |
| Standard Deviation | 4,189,316,191 | |
| Sample Variance | 17550370.1T | |
| Range | 16.1B | |
| R-Value | 0.64 | |
| Mean Square Error | 11158777.9T | |
| R-Squared | 0.41 | |
| Significance | 0.01 | |
| Slope | 599,526,806 | |
| Total Sum of Squares | 245705182.1T |
Incyte Market Capitalization History
About Incyte Financial Statements
Incyte investors use historical fundamental indicators, such as Incyte's Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Incyte. Please read more on our technical analysis and fundamental analysis pages.
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware. Incyte Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2094 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Incyte Stock Analysis
When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.